Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg)-Reference-Cited by-同舟云学术

Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg)

Published:2017-08 Issue: Volume:144 Page:153-163
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Golsaz-Shirazi Forough,Amiri Mohammad Mehdi,Farid Samira,Bahadori Motahareh,Bohne Felix,Altstetter Sebastian,Wolff Lisa,Kazemi Tohid,Khoshnoodi Jalal,Hojjat-Farsangi Mohammad,Chudy Michael,Jeddi-Tehrani Mahmood,Protzer Ulrike,Shokri Fazel

Funder

Avicenna Research Institute

Iran National Science Foundation

Tehran University of Medical Sciences

Technische Universität München

German Excellence Initiative

EU 7th Framework Programme

German Research Foundation (DFG) through the collaborative research center

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference45 articles.

1. HBsAg variants: diagnostic-escape and diagnostic dilemma;Alavian;J. Clin. Virol.,2013

2. Infectivity of blood products from donors with occult hepatitis B virus infection;Allain;Transfusion,2013

3. Construction and characterization of a new chimeric antibody against HER2;Amiri;Immunotherapy,2013

4. Multiple hepatitis B virus (HBV) quasispecies and immune-escape mutations are present in HBV surface antigen and reverse transcriptase of patients with acute hepatitis B;Aragri;J. Infect. Dis.,2016

5. High affinity mouse-human chimeric Fab against Hepatitis B surface antigen;Bose;World J. Gastroenterol.,2005

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel neutralizing mouse-human chimeric monoclonal antibodies against the SARS-CoV-2 receptor binding domain;Journal of Medical Microbiology;2023-06-30

2. Therapies against chronic hepatitis B infections: The times they are a-changin’, but the changing is slow!;Antiviral Research;2023-02

3. Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance;JHEP Reports;2023-02

4. Optimization of an Efficient Cell Culture Hepatitis B Infection System for Assessment of Hepatitis B Virus Neutralizing Monoclonal Antibodies;IRAN J IMMUNOL;2022

5. Neutralization of tetanus toxin by a novel chimeric monoclonal antibody;Toxicon;2021-10